Aterian, Inc. ATER
Company Overview
Aterian, Inc., together with its subsidiaries, operates as a consumer products company in North America, Chile, Colombia, Argentina, and internationally. The company offers home and kitchen appliances, kitchenware, air quality appliances, health and beauty products, and essential oils under the Squatty Potty, HomeLabs, Mueller Living, PurSteam, Healing Solutions, and Photo Paper Direct brand names. It primarily serves individual online consumers through online retail channels, such as Amazon, Walmart, and Target; Amazon US, owned and operated websites; and other marketplaces. The company was formerly known as Mohawk Group Holdings, Inc. and changed its name to Aterian, Inc. in April 2021. Aterian, Inc. was founded in 2014 and is headquartered in Summit, New Jersey., Chile, Colombia, Argentina, and internationally.
Why Investors Should Care
Carries low leverage with a debt-to-equity ratio of 0.30.
Recent Developments
- Dec 2025 Revenue of $68.97M (-30.4% YoY); net profit $-18.98M.
- Trailing 12 Months Year-on-year growth — revenue -92.0%.
- 5-Year Trend Long-term compounding — revenue CAGR -0.9%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -0.86% |
| 1 Year: | -92.00% |
Stock Price Performance
| 1 Year: | -25.36% |
| 6 Months: | +31.50% |
| 3 Months: | -34.96% |
| 1 Month: | +47.77% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- Death Cross6d ago
- RSI (14)67.45 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Revenue declined at -0.9% CAGR over 5 years.
- Trading 47.6% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Consumer Cyclical).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ATER Aterian, Inc. | 0.73 | -0.32 | $13.12M | 0.00% | -116.44% | -104.03% | -0.86% | - |
| 2 | AMZN Amazon.com, Inc. NDXSPXR3KAITECH | 256.97 | 20.66 | $2.77T | 0.00% | 13.33% | 30.56% | 24.04% | 32.72% |
| 3 | TSLA Tesla, Inc. NDXSPXR3KAI | 368.16 | 347.32 | $1.45T | 0.00% | 4.10% | 4.67% | 52.40% | 39.39% |
| 4 | HD The Home Depot, Inc. SPXR3K | 313.70 | 21.97 | $312.98B | 3.08% | 28.75% | 104.30% | 4.06% | 6.35% |
| 5 | BABA Alibaba Group Holding Limited AITECH | 112.66 | 25.43 | $280.03B | 0.93% | 4.16% | 6.36% | 5.62% | 12.49% |
| 6 | TM Toyota Motor Corporation | 191.45 | 8.46 | $226.71B | 3.23% | 5.24% | 12.40% | 10.91% | 16.22% |
| 7 | MCD McDonald's Corporation SPXR3K | 255.81 | 20.80 | $181.02B | 2.99% | 22.47% | - | 0.92% | 7.33% |
| 8 | TJX The TJX Companies, Inc. SPXR3K | 128.92 | 23.87 | $142.42B | 1.52% | 21.26% | 62.17% | 6.84% | 8.48% |
| 9 | BKNG Booking Holdings Inc. NDXSPXR3K | 180.30 | 20.03 | $139.71B | 0.87% | 70.23% | -96.88% | 16.93% | 22.07% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2018 | Sep 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14.59M | 24.67M | 17.85M | 30.37M | 40.60M | 25.63M | 59.80M | 58.78M | 48.14M | 68.19M | 68.12M | 41.67M | 58.27M | 66.33M | 34.88M | 35.26M | 39.67M | 20.21M | 27.98M | 26.24M | 63.00K | 19.46M | 19.02M | 18.00K |
| Gross Profit | 3.78M | 10.41M | 6.67M | 11.76M | 17.53M | 10.30M | 27.60M | 28.09M | 26.06M | 32.74M | 34.17M | 23.61M | 31.35M | 30.19M | 19.10M | 14.90M | 19.58M | 13.17M | 16.89M | 15.83M | 50.00K | 10.57M | 10.67M | 10.00K |
| Operating Income | -8.41M | -4.71M | -7.13M | -15.60M | -14.07M | -13.90M | -1.82M | 106.00K | -27.75M | 4.47M | -7.53M | -36.30M | -10.12M | -108.94M | -25.00M | -36.44M | -6.52M | -5.28M | -3.21M | -1.73M | -3.34M | -4.50M | -2.04M | -3.21M |
| Net Income | -8.94M | -5.13M | -8.39M | -16.88M | -14.97M | -15.03M | -2.94M | -805.00K | -82.55M | -36.31M | -110.56M | -42.78M | -16.31M | -116.90M | -25.80M | -34.79M | -6.27M | -5.16M | -3.63M | -1.77M | -3.90M | -4.86M | -2.28M | -6.13M |
| Diluted EPS | - | - | - | - | - | - | - | - | - | -1.23 | -3.13 | -0.78 | -0.26 | -1.81 | -0.34 | -0.45 | - | - | - | - | - | - | - | - |
| R&D Expense | 897.00K | 790.00K | 1.16M | 3.34M | 3.23M | 2.28M | 2.45M | 1.85M | 2.12M | 2.32M | 2.77M | 1.14M | 1.73M | 1.71M | 1.25M | 1.71M | 852.00K | 0 | 0 | 0 | - | - | - | - |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 73.28M | 114.45M | 185.70M | 247.77M | 221.17M | 142.57M | 99.05M | 68.97M |
| Gross Profit | 25.98M | 45.04M | 84.75M | 121.86M | 105.52M | 70.28M | 61.49M | 39.15M |
| Operating Income | -29.43M | -54.33M | -34.75M | -34.08M | -178.16M | -76.19M | -11.82M | -17.97M |
| Net Income | -31.82M | -58.79M | -63.13M | -236.02M | -196.29M | -74.56M | -11.86M | -18.98M |
| Diluted EPS | - | - | - | -6.67 | -2.95 | - | - | - |
| R&D Expense | 3.65M | 10.66M | 8.13M | 9.84M | 6.01M | 4.62M | 0 | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | 58.01M | 74.42M | 157.45M | 313.57M | 156.44M | 61.87M | 49.54M | 29.56M |
| Total Equity | 8.15M | 5.37M | 10.73M | 23.38M | 224.23M | 101.95M | 36.03M | 30.02M | 15.21M |
| Cash & Equivalents | - | 20.03M | 30.35M | 26.72M | 30.32M | 43.57M | 20.02M | 18.00M | 4.86M |
| Long Term Debt | - | - | 35.10M | - | - | - | - | - | - |
| Total Liabilities | - | 52.64M | 63.70M | 134.07M | 89.34M | 54.49M | 25.84M | 19.52M | 14.35M |
| Current Liabilities | - | 39.56M | 53.23M | 74.73M | 83.74M | 53.03M | 25.45M | 19.30M | 14.13M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -30.34M | -25.20M | 6.09M | - | -17.48M | -13.39M | 2.17M | -10.89M |
| Investing Cash Flow | -26.00K | -1.28M | -39.05M | - | -677.00K | -244.00K | -242.00K | -51.00K |
| Financing Cash Flow | 45.29M | 36.57M | 32.32M | - | 27.00M | -11.11M | -4.91M | -2.52M |
| Capital Expenditure | -61.00K | -114.00K | -89.00K | - | -82.00K | -119.00K | -42.00K | -51.00K |
| Free Cash Flow | -30.41M | -25.31M | 6.00M | - | -17.56M | -13.51M | 2.12M | -10.95M |
| Net Change in Cash | - | - | - | - | 8.84M | -24.74M | -2.99M | -13.46M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 35.5% | 39.4% | 45.6% | 49.2% | 47.7% | 49.3% | 62.1% | 56.8% |
| Operating Margin % | -40.2% | -47.5% | -18.7% | -13.8% | -80.6% | -53.4% | -11.9% | -26.1% |
| Net Margin % | -43.4% | -51.4% | -34.0% | -95.3% | -88.8% | -52.3% | -12.0% | -27.5% |
| ROE % | -592.7% | -548.0% | -270.0% | -105.3% | -192.5% | -206.9% | -39.5% | -124.8% |
| ROCE % | -159.6% | -256.3% | -42.0% | -14.8% | -172.3% | -209.2% | -39.1% | -116.4% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Renaissance Technologies, LLC | 2.48% | 446.06K | $312.20K |
| 2 | Blackrock Inc. | 0.80% | 144.58K | $101.19K |
| 3 | Geode Capital Management, LLC | 0.68% | 122.26K | $85.57K |
| 4 | Vanguard Capital Management LLC | 0.64% | 114.09K | $79.85K |
| 5 | Bridgeway Capital Management, LLC | 0.58% | 105.00K | $73.49K |
| 6 | Jane Street Group, LLC | 0.55% | 98.70K | $69.08K |
| 7 | Susquehanna International Group, LLP | 0.53% | 95.64K | $66.94K |
| 8 | Xtx Topco Ltd | 0.35% | 62.56K | $43.78K |
| 9 | Vanguard Fiduciary Trust Co | 0.29% | 51.99K | $36.39K |
| 10 | State Street Corporation | 0.27% | 48.01K | $33.60K |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ATER
Novartis Stock Drops After Another Trial Setback - WSJ
<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxPelFWUVdJZEY0SVFrWjlrTUdJa3VzTDNZaUFrRDZGdEJabXNMalBlOUhZX2VWVVhINmdDeXRyY3pVaUItelZjajFXeTJYaXFRWFUyZ21CUndUdThNSzNiQU5SYzlFMG9VSTUzRFhjU2RvaEt0akxueW1BS3FQaEdUeFZMLUVXMnlkaG1wVG…
Nvidia supplier Wistron's shares drop after it announces $1.5 billion global stock sale - CNBC
<a href="https://news.google.com/rss/articles/CBMie0FVX3lxTFA3cUkxRTNkckFPV0E1alVORURUem9QV3RSYWxaV1RScXY5X200LWRWVU02WVdjUHlrTElOd1loNlYwcmFJdTRUWGUwX01GdUcydjJySHlxVGVJWFEycjlHQW1RQm93czVPdEdvMTB3eVcwX1Uwb0N4R2NoZ9IBgAFBVV95cUxQSlprSjA1bj…
12 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session - Benzinga
<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxOS0QyclJLeTkxMWktRjdtUnpHQjZ5N3lXdExnRV94YjdUMmJQVU9RWlN5M29BOFk0c3dkdWg5Y3ZqNVhwM0ZQb3BDd1Q3a2h3VXh5dXB1aXhHNDUwYzRqalB3eDNVOHFjM2lXYjZrX1JScXdINU9WWnVhakQtcHJYVE5OM0FaVEpMUy1ZMD…
Pharma major Novartis falls 10% after three drug trial setbacks - CNBC
<a href="https://news.google.com/rss/articles/CBMifkFVX3lxTE9WRTg5RHNwODJqN0twNlIteDJySzZOWk9CZXU0QzlZQmZram5Ya3QzeUhCTzdOQmJGX2NnenB2VTB0STZpMmJBLVZCYWZRUHB4elFZTER3WXp1b25sSGVxYXBfX09nM1J6VVJUMGlBVFl0MWd2Sm5vaWpGS2RXQdIBgwFBVV95cUxOZFNRTn…
Insider Dumps $1.1 Million Worth of Stock, After Stock Plunges 72% - The Motley Fool
<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxOVWtmUWZYTklhaENQMU93Zno4amVQZDlMbHlvS1dIenI5bjEycm9HaHNrTk5VbHMzeGdnM1U1WC04eVBkdzNFUGhOY0pVXzBjemo4NWJIcFQyZWFydU91N1RWZTN5QkpGY29UUXpXeEZfYm9mclo5S1V0VnA1dXdPeXp5Q2l2NWsxWmZhT1…
AMD Worth Nearly As Much As JPMorgan After Stock Breaks $500 Level: Retail Confidence Climbs - Stocktwits
<a href="https://news.google.com/rss/articles/CBMi6wFBVV95cUxOUDdZNnpDdDNnOElNU0xWM1hOaEM3bzVHSVZxS01QZXVWMUI5TEh2VklvTjRyTmRVakhYd0R5V1ZzdkVyT3p4T2xtZWd2dUNIS0NNUzNrWS1mZWVnZERNYXkyN0VCOE1SaloybjlxVWc3VEJ6Q24zYmp4M3VNbkxiNjlZMTU3OVNhaUlERn…
ATER — Frequently Asked Questions
What is the current share price of Aterian, Inc. (ATER)?
As of 2026-09-19 21:16 PDT, Aterian, Inc. (ATER) trades at $0.73 on NasdaqCM. Its 52-week range is $0.36 to $1.39.
What is the market capitalisation of ATER?
Aterian, Inc. (ATER) has a market capitalisation of $13.12M on NasdaqCM.
What is the P/E ratio of ATER?
ATER trades at a trailing price-to-earnings (P/E) ratio of -0.32. The industry average P/E is 18.98. Its price-to-book (P/B) ratio is 0.52.
What is the return on equity (ROE) of ATER?
ATER has a return on equity (ROE) of -104.03%. Its return on capital employed (ROCE) is -116.44%.
Is ATER a good stock to buy?
This page provides a data-driven analysis of Aterian, Inc. (ATER), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.